Vinflunine

Javlor 25 mg/ml, Concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 21 Sept 2009

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

JavlorEuropean UnionAuthorised

JavlorBrazil · Laboratórios Pierre Fabre do Brasil LtdaSame brand
JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 25 mg · concentrado para solución para perfusión · Pierre Fabre MedicamentSame brand
JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 25 mg · concentrado para solución para perfusión · Pierre Fabre MedicamentSame brand
JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 25 mg · concentrado para solución para perfusión · Pierre Fabre MedicamentSame brand
JavlorEuropean Union · Pierre Fabre Medicament

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vinflunine

Javlor 25 mg/ml, Concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 21 Sept 2009

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

JavlorEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

JavlorCroatia

JavlorItaly · Concentrato per soluzione per infusione · Pierre Fabre Medicament

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vinflunine
Dosage form: Concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 21 Sept 2009
Registration: EU/1/09/550
Marketing authorisation holder: Pierre Fabre Medicament
ATC code: L01CA05
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/000983
EU number: EU/1/09/550